HomeCompareRMD vs CB

RMD vs CB: Dividend Comparison 2026

RMD yields 1.06% · CB yields 1.19%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RMD wins by $5.7K in total portfolio value· pulled ahead in Year 2
10 years
RMD
RMD
● Live price
1.06%
Share price
$220.03
Annual div
$2.33
5Y div CAGR
35.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.7K
Annual income
$3,288.25
Full RMD calculator →
CB
CB
● Live price
1.19%
Share price
$325.35
Annual div
$3.88
5Y div CAGR
23.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.0K
Annual income
$1,241.17
Full CB calculator →

Portfolio growth — RMD vs CB

📍 RMD pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRMDCB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RMD + CB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RMD pays
CB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RMD
Annual income on $10K today (after 15% tax)
$90.01/yr
After 10yr DRIP, annual income (after tax)
$2,795.01/yr
CB
Annual income on $10K today (after 15% tax)
$101.37/yr
After 10yr DRIP, annual income (after tax)
$1,054.99/yr
At 15% tax rate, RMD beats the other by $1,740.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RMD + CB for your $10,000?

RMD: 50%CB: 50%
100% CB50/50100% RMD
Portfolio after 10yr
$28.9K
Annual income
$2,264.71/yr
Blended yield
7.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CB right now

RMD
Analyst Ratings
16
Buy
14
Hold
5
Sell
Consensus: Buy
Price Target
$295.88
+34.5% upside vs current
Range: $265.00 — $345.00
Altman Z
11.6
Piotroski
7/9
CB
Analyst Ratings
1
Strong
22
Buy
18
Hold
2
Sell
Consensus: Buy
Price Target
$342.00
+5.1% upside vs current
Range: $305.00 — $373.00
Altman Z
1.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RMD buys
0
CB buys
0
No recent congressional trades found for RMD or CB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRMDCB
Forward yield1.06%1.19%
Annual dividend / share$2.33$3.88
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR35.9%23.5%
Portfolio after 10y$31.7K$26.0K
Annual income after 10y$3,288.25$1,241.17
Total dividends collected$10.4K$5.2K
Payment frequencyquarterlyquarterly
SectorHealthcareFinancials
Analyst consensusBuyBuy
Analyst price target$295.88$342.00

Year-by-year: RMD vs CB ($10,000, DRIP)

YearRMD PortfolioRMD Income/yrCB PortfolioCB Income/yrGap
1$10,844$143.91$10,847$147.28$3.00CB
2← crossover$11,801$198.21$11,791$184.40+$10.00RMD
3$12,901$273.96$12,848$231.35+$53.00RMD
4$14,185$380.39$14,038$290.95+$147.00RMD
5$15,709$531.20$15,388$366.93+$321.00RMD
6$17,556$747.16$16,929$464.23+$627.00RMD
7$19,845$1,060.53$18,703$589.49+$1.1KRMD
8$22,757$1,522.63$20,764$751.71+$2.0KRMD
9$26,567$2,217.64$23,181$963.24+$3.4KRMD
10$31,715$3,288.25$26,045$1,241.17+$5.7KRMD

RMD vs CB: Complete Analysis 2026

RMDHealthcare

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Full RMD Calculator →

CBFinancials

Chubb Limited provides insurance and reinsurance products worldwide. The company's North America Commercial P&C Insurance segment offers commercial property, casualty, workers' compensation, package policies, risk management, financial lines, marine, construction, environmental, medical, cyber risk, surety, and excess casualty; and group accident and health insurance to large, middle market, and small commercial businesses. Its North America Personal P&C Insurance segment provides affluent and high net worth individuals and families with homeowners, automobile and collector cars, valuable articles, personal and excess liability, travel insurance, and recreational marine insurance and services. The company's North America Agricultural Insurance segment offers multiple peril crop and crop-hail insurance; and coverage for farm and ranch property, and commercial agriculture products. Its Overseas General Insurance segment provides coverage for traditional commercial property and casualty; specialty categories, such as financial lines, marine, energy, aviation, political risk, and construction risk; and group accident and health, and traditional and specialty personal lines for corporations, middle markets, and small customers through retail brokers, agents, and other channels. The company's Global Reinsurance segment offers traditional and specialty reinsurance under the Chubb Tempest Re brand to property and casualty companies. Its Life Insurance segment provides protection and savings products comprising whole life, endowment plans, individual term life, group term life, medical and health, personal accident, credit life, universal life, and unit linked contracts. The company markets its products primarily through insurance and reinsurance brokers. The company was formerly known as ACE Limited and changed its name to Chubb Limited in January 2016. Chubb Limited was incorporated in 1985 and is headquartered in Zurich, Switzerland.

Full CB Calculator →
📬

Get this RMD vs CB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RMD vs SCHDRMD vs JEPIRMD vs ORMD vs KORMD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.